Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

VRE Outbreaks in Switzerland

ABSTRACT: Patients exposed to vancomycin resistant enterococci (VRE) during in-hospital outbreaks in a low endemic setting: who is at risk for acquisition? Report of three outbreaks with VRE in Switzerland, 2018-2019

PROVIDER: PRJEB41046 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR5555420_1.fastq.gz	Fastqsanger.gz
	ERR5555420_2.fastq.gz	Fastqsanger.gz
	ERR5555430_1.fastq.gz	Fastqsanger.gz
	ERR5555430_2.fastq.gz	Fastqsanger.gz
	ERR5555440_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 76

Similar Datasets

VRE ST796 in Switzerland

Project description:Sequencing of VRE in Switzerland, 2018

| PRJEB27159 | ENA

Enterococcus

Project description:Vancomycin-Resistant Enterococci (VRE)

| PRJNA635383 | ENA

Project description:MDU PHL Vancomycin-resistant Enterococci (VRE)

| PRJNA495857 | ENA

VRE Control study

Project description:Impact of single room contact precautions on hospital-acquisition and transmission of vancomycin-resistant enterococci in a high-risk setting

| PRJEB25579 | ENA

VRE outbreaks: clonal spread and movement of MGEs

Project description:Elucidating vancomycin-resistant E. faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.

| PRJEB25590 | ENA

A comprehensive microarray analysis of Enterococcus faecium in response to vancomycin in combination with the essential oil components carvacrol and cuminaldehyde

Project description:This study aims to determine the global gene expression in vancomycin resistant Enterococcus faecium (VRE) in response to a novel essential oil-vancomycin combination, and the individual components (vancomycin, carvacrol and cuminaldehyde) to help determine the mechanism of action of this antimicrobial formulation. This formulation increases the susceptibility of VRE to vancomycin and the array provides data on the synergistic mechanism of action. Five conditions (1. Control; 2. Carvacrol, 1.98 mM; 3. Cuminaldehyde, 4.20 mM; 4. Vancomycin, 0.031 mg/l; 5. Combination, 1.98 mM Carvacrol, 4.2 mM Cuminaldehyde, 0.031 mg/l vancomycin) all with 1% DMSO were tested in triplicate with a 60 minute exposure time before extraction.

2019-12-31 | E-MTAB-8072 | biostudies-arrayexpress

Project description:The first Norwegian vanD-type vancomycin resistant enterococci (VRE)

| PRJNA627463 | ENA

Cajanin Stilbene Acid Inhibited Vancomycin-Resistant Enterococci By Inhibiting Phosphotransferase System

Project description:In order to determine the mechanism of Cajanin Stilbene Acid inhibiting vancomycin-resistant enterococci, we compared the changes in protein expression of enterococci V583 strain before and after treated by Cajanin Stilbene Acid.

2020-05-27 | PXD017522 | Pride

Project description:Vancomycin resistant enterococci

| PRJNA627548 | ENA

Study of clinical VRE

Project description:Study of clinical VRE

| PRJEB13267 | ENA